Several important signaling pathways, such as mTOR/HIF-1α, TGF-β1/Smads, and JAK2/STAT6, are involved in the effect of paeoniflorin on activated HSC and ECM inhibition during liver fibrosis. This evidence concerns the gene STAT6 and Hepatic fibrosis.